PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT)
Objectives: Hyperactivation of the phosphatidylinositol-3-kinase (PI3K) pathway has been associated with radioresistance. It is unclear whether such mutations confer suboptimal local control for patients who receive lung stereotactic body radiation therapy (SBRT). Our objective was to examine whethe...
Main Authors: | Natalie A. Lockney, T. Jonathan Yang, David Barron, Emily Gelb, Daphna Y. Gelblum, Ellen Yorke, Weiji Shi, Zhigang Zhang, Andreas Rimner, Abraham J. Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Clinical and Translational Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405630817300812 |
Similar Items
-
Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) Cost-Effectiveness Results
by: Akash eBijlani, et al.
Published: (2013-04-01) -
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma
by: Robert C. Miller, et al.
Published: (2010-08-01) -
Stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic prostate cancer
by: Kamran Ali Ahmed, et al.
Published: (2013-01-01) -
Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)
by: John Nikitas, et al.
Published: (2020-03-01) -
Stereotactic Body Radiation Therapy (SBRT) for prostate cancer: Preliminary results of toxicity
by: Asmaa Naim, et al.
Published: (2021-10-01)